KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Change in Acquisitions & Divestments (2017 - 2025)

Historic Change in Acquisitions & Divestments for Twist Bioscience (TWST) over the last 9 years, with Q4 2025 value amounting to $20.6 million.

  • Twist Bioscience's Change in Acquisitions & Divestments fell 363.42% to $20.6 million in Q4 2025 from the same period last year, while for Dec 2025 it was $49.4 million, marking a year-over-year decrease of 365.96%. This contributed to the annual value of $50.1 million for FY2025, which is 700.24% down from last year.
  • Per Twist Bioscience's latest filing, its Change in Acquisitions & Divestments stood at $20.6 million for Q4 2025, which was down 363.42% from $21.2 million recorded in Q3 2025.
  • In the past 5 years, Twist Bioscience's Change in Acquisitions & Divestments registered a high of $112.0 million during Q2 2021, and its lowest value of $2.0 million during Q2 2024.
  • In the last 5 years, Twist Bioscience's Change in Acquisitions & Divestments had a median value of $21.9 million in 2024 and averaged $31.1 million.
  • As far as peak fluctuations go, Twist Bioscience's Change in Acquisitions & Divestments surged by 31764.83% in 2023, and later tumbled by 9354.84% in 2024.
  • Twist Bioscience's Change in Acquisitions & Divestments (Quarter) stood at $12.0 million in 2021, then soared by 129.17% to $27.5 million in 2022, then decreased by 12.73% to $24.0 million in 2023, then decreased by 11.15% to $21.3 million in 2024, then dropped by 3.63% to $20.6 million in 2025.
  • Its last three reported values are $20.6 million in Q4 2025, $21.2 million for Q3 2025, and $7.6 million during Q1 2025.